US2011207707A1PendingUtilityA1

Compounds That Act To Modulate Insect Growth And Methods And Systems For Identifying Such Compounds

Individually held — no corporate assignee on recordPriority: Aug 29, 2003Filed: Jul 26, 2010Published: Aug 25, 2011
Est. expiryAug 29, 2023(expired)· nominal 20-yr term from priority
G01N 2333/43552A01N 61/00C12Q 1/6897G01N 33/743
42
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods and systems for screening for compounds that act to modulate insect growth. Bioassays including cell culture and/or transgenic insects engineered with various components of the ecdysoid receptor (EcR) and/or the farsenoid-X receptor (RXR) systems to identify compounds that act as insecticides and/or hormone receptor activators are described. Also described are compounds, and compositions, identified as being putative insecticides based upon their ability to activate EcR and/or FXR mediated transcription.

Claims

exact text as granted — not AI-modified
1 . A method for testing the ability of a compound to act as a modulator of insect growth comprising determining whether the compound increases farnesoid X-activated receptor (FXR)-mediated transcription and/or ecdysone receptor (EcR)-mediated transcription. 
     
     
         2 . The method of  claim 1 , wherein the increase of EcR-mediated transcription comprises potentiation of hormone-activated EcR-mediated transcription. 
     
     
         3 . The method of  claim 2 , wherein the hormone comprises an ecdysteroid. 
     
     
         4 . The method of  claim 3 , wherein the hormone comprises muristerone A (murA) or 20-hydroxyecdysone (20E). 
     
     
         5 . The method of  claim 1 , comprising the steps of:
 (a) transfecting isolated cells with DNA comprising sequences that encode a functional isoform of the ecdysone receptor (EcR) or the farnesoid receptor (FXR);   (b) cotransfecting the cell with: (i) DNA comprising sequences that encode a functional heterologous binding partner for (a), wherein said heterologous binding partner complexes with either EcR or FXR, and wherein said complex binds to a hormone responsive element (HRE) on DNA to activate gene transcription; and (ii) DNA comprising a reporter construct comprising a hormone response element (HRE) linked to a gene;   (c) adding the compound to be tested; and   (d) measuring an increase in the synthesis of the reporter gene protein.   
     
     
         6 . The method of  claim 5 , wherein the increase in reporter gene protein is used to quantify the ability of the test compound to increase EcR-mediated transcription or FXR-mediated transcription. 
     
     
         7 . The method of  claim 6 , wherein the ability of the test compound to activate EcR-mediated transcription or FXR-mediated transcription is correlated to the potential insecticidal activity of the test compound. 
     
     
         8 . The method of  claim 5 , wherein the heterologous binding partner comprises Ultraspiracle (USP). 
     
     
         9 . The method of  claim 5 , wherein the heterologous binding partner comprises a retinoid X receptor (RXR). 
     
     
         10 . The method of  claim 5 , further comprising adding a modulator of EcR activity to the cell. 
     
     
         11 . A method for in situ testing for the presence of compound having the ability to act as a modulator of insect growth comprising:
 (a) transfecting a cell in an organism with DNA that encodes a functional isoform of the farnesoid X-activated receptor (FXR) and/or the ecdysone receptor (EcR);   (b) cotransfecting the cell with: (i) DNA that encodes a polypeptide comprising a functional retinoid X receptor (RXR) or Ultraspiracle (USP) isoform; and (ii) DNA comprising a hormone response element (HRE) linked to a reporter gene;   (c) optionally adding an ecdysteroid;   (d) exposing the organism to a compound to be tested; and   (e) measuring an increase in the protein encoded by the reporter gene.   
     
     
         12 . The method of  claim 11 , wherein the organism comprises a natural or modified eukaryotic cell. 
     
     
         13 . The method of  claim 11 , wherein the reporter construct comprises a promoter comprising multiple hormone response elements (HREs) linked to a gene encoding a detectable gene product. 
     
     
         14 . The method of  claim 11 , wherein the reporter gene comprises luciferase (LUC). 
     
     
         15 . The method of  claim 11 , wherein the hormone response element comprises a EcR response element. 
     
     
         16 . The method of  claim 11 , wherein the hormone response element comprises a FXR response element. 
     
     
         17 . A composition for use as an insecticide comprising a compound that increases FXR-mediated transcription or EcR-mediated transcription mixed with a suitable carrier for application to plants. 
     
     
         18 . The composition of  claim 17 , wherein the increase in EcR-mediated transcription comprises potentiation of hormone-activated EcR transcription. 
     
     
         19 . The composition of  claim 17 , wherein the hormone comprises an ecdysteroid.

Join the waitlist — get patent alerts

Track US2011207707A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.